Recombinant Human Putative mitochondrial import inner membrane translocase subunit Tim23B (TIMM23B)

Basic Research Questions

• What is TIMM23B and what is its basic function in mitochondria?

  TIMM23B (translocase of inner mitochondrial membrane 23 homolog B) is a protein-coding gene located on chromosome 10. It plays a critical role in the mitochondrial protein import pathway, specifically in moving proteins with transit peptides across the mitochondrial inner membrane . TIMM23B likely functions as part of the presequence translocase-associated motor (PAM) complex, which drives the ATP-dependent translocation of preproteins into the mitochondrial matrix .

  Methodology for studying basic TIMM23B function:

  • Subcellular fractionation techniques to isolate mitochondria

  • Immunoblotting with TIMM23B-specific antibodies

  • Blue native PAGE to analyze native protein complexes

  • Fluorescence microscopy with tagged TIMM23B constructs to confirm mitochondrial localization

• How does TIMM23B relate to TIMM23 and what is known about their evolutionary relationship?

  TIMM23B and TIMM23 are paralogs with highly similar functions in the mitochondrial import machinery. Both proteins form part of the core TIM23 complex, serving as channel-forming subunits that facilitate protein translocation across the inner mitochondrial membrane . Computational structure prediction analysis reveals that human TIMM23 and TIMM23B form highly similar structures to their yeast counterparts, indicating strong evolutionary conservation of these critical mitochondrial import components .

  Evolutionary analysis methods:

  Species	TIMM23 homolog	TIMM23B homolog	Sequence identity to human (%)
  Human	TIMM23	TIMM23B	100
  Mouse	TIMM23	TIMM23B	~90
  Yeast	Tim23	N/A	~40
  C. elegans	TIMM-23	N/A	~35

  • Comparative genomics approaches

  • Phylogenetic tree construction

  • Homology modeling of protein structures

  • Analysis of conserved functional domains

• What diseases are associated with TIMM23B dysfunction?

  TIMM23B dysfunction has been associated with several diseases, primarily affecting tissues with high metabolic demands. These include:

  • Hypotrichosis simplex

  • Trichodysplasia-xeroderma syndrome

  • Alopecia universalis congenita

  • Hypotrichosis 4 and 5

  • Uncombable hair syndrome

  • Clouston syndrome

  • Pure hair and nail ectodermal dysplasia

  • Alzheimer disease

  • Progressive supranuclear palsy

  Methods to investigate disease associations:

  • Genome-wide association studies (GWAS)

  • Patient tissue immunohistochemistry for TIMM23B expression

  • Sequencing of TIMM23B in patient populations

  • Development of disease-specific cellular and animal models

Advanced Research Questions

• What are the structural features of TIMM23B and how can one model its functional domains?

  TIMM23B, like TIMM23, is predicted to contain multiple transmembrane domains that form a channel across the inner mitochondrial membrane. Recent computational structure prediction analyses using AlphaFold2.3 multimer model have revealed that human TIMM23B forms structurally similar complexes with either TIMM17A or TIMM17B .

  The channel formed by TIMM23B contains:

  • Acidic residues at the intermembrane space (IMS) entrance that attract positively charged presequences

  • Hydrophobic lining of the cavity that facilitates protein translocation

  • Conserved interface regions for interaction with other components of the TIM23 complex

  Structural analysis methods:

  • Computational modeling using AlphaFold2.3 or similar tools

  • Validation through site-directed mutagenesis of key residues

  • Cross-linking mass spectrometry to identify interaction interfaces

  • Cryo-EM or X-ray crystallography for high-resolution structural determination

• How can one experimentally manipulate TIMM23B expression and what are the expected cellular effects?

  TIMM23B expression can be modulated through various molecular biological techniques, with significant consequences for mitochondrial function and cell survival. Based on studies with TIMM23, we can expect similar outcomes when manipulating TIMM23B.

  Experimental manipulation strategies:

  Approach	Methodology	Expected Effects	Validation Methods
  shRNA knockdown	Lentiviral transduction with TIMM23B-targeting shRNAs, puromycin selection	Reduced complex I activity, ATP depletion, mitochondrial membrane potential dissipation, oxidative stress	qPCR, Western blot, mitochondrial function assays
  CRISPR/Cas9 knockout	Lentiviral delivery of Cas9 and TIMM23B-targeting sgRNAs	Severe mitochondrial dysfunction, potential cell death in highly metabolic cells	Deep sequencing, protein absence verification, mitochondrial morphology assessment
  Overexpression	Lentiviral transduction with TIMM23B cDNA	Enhanced mitochondrial complex I activity, increased ATP production, potential proliferative advantage	Verification of expression, mitochondrial function assessment
  In vivo modulation	Intratumoral delivery of TIMM23B shRNA-expressing AAV	Reduced tissue expression, metabolic alterations, potential therapeutic benefit in disease models	Tissue analysis for protein levels, functional readouts

• What is the relationship between TIMM23B and the prohibitin complex in mitochondrial biogenesis?

  Recent research has uncovered a critical relationship between the prohibitin complex (PHB complex) and the biogenesis and stability of TIM23 complexes containing either TIMM17A or TIMM17B. The prohibitin complex interacts with and stabilizes both variants of the TIM23 complex, including those containing TIMM23B .

  The ovarian cancer immunoreactive antigen domain-containing protein 1 (OCIAD1) assembles with the prohibitin complex to specifically protect the TIMM17A variant from degradation by the YME1L protease. This suggests that TIMM23B-containing complexes may be regulated differently and potentially less dependent on OCIAD1 for stability .

  Research methodology:

  • Co-immunoprecipitation to identify physical interactions

  • Blue native PAGE to analyze complex formation

  • Proximity labeling techniques like BioID or APEX to map interaction networks

  • Protease protection assays to assess stability

  • Pulse-chase experiments to measure protein turnover rates

• How does TIMM23B contribute to mitochondrial bioenergetics and what methodologies can measure this contribution?

  Based on studies of TIMM23, TIMM23B likely plays a crucial role in maintaining mitochondrial bioenergetics through facilitating the import of essential proteins required for oxidative phosphorylation and other metabolic pathways.

  Methodological approaches to assess bioenergetic contributions:

  Assay	Parameter Measured	Technical Approach	Relevance to TIMM23B
  Complex I activity	NADH to NAD+ conversion	Spectrophotometric measurement at 380nm	TIMM23B knockdown reduces activity
  ATP content	Cellular ATP levels	Colorimetric or luminescence-based assays	TIMM23B depletion leads to ATP reduction
  Mitochondrial membrane potential	Proton gradient across inner membrane	JC-1 fluorescence (red/green ratio)	TIMM23B knockdown causes membrane depolarization
  ROS production	Reactive oxygen species levels	CellROX or DCF-DA fluorescence	TIMM23B silencing increases oxidative stress
  Lipid peroxidation	Oxidative damage to lipids	TBAR fluorescence intensity	TIMM23B depletion enhances lipid peroxidation
  Oxygen consumption rate	Mitochondrial respiration	Seahorse XF analyzer measurements	Expected to decrease with TIMM23B knockdown

• What are the differences in function between TIMM17A-TIMM23B and TIMM17B-TIMM23B complexes?

  TIMM23B can form complexes with either TIMM17A or TIMM17B, creating two distinct populations of TIM23 complexes. Research suggests that TIMM17B-containing TIM23 translocase plays a housekeeping role with higher import efficiency, whereas TIMM17A-containing complexes may have secondary roles with lower import rates .

  TIMM17A is degraded in response to various cellular stressors to reduce mitochondrial import and rewire metabolism, suggesting that TIMM23B complexes with TIMM17A might be more responsive to stress conditions . Additionally, TIMM17A has been implicated in breast cancer, indicating potential tissue-specific functions or pathological roles of different TIM23 complex compositions .

  Methods to distinguish and characterize the complexes:

  • Specific antibody pull-downs to isolate distinct complexes

  • Comparative proteomics to identify unique interacting partners

  • In vitro import assays with recombinant complexes

  • Selective knockdown of TIMM17A vs. TIMM17B to assess differential impacts

• How can transcriptional regulation of TIMM23B be studied, and what factors control its expression?

  The transcriptional regulation of TIMM23B can be studied using various molecular biology techniques. Research on the promoter regions of TIMM23 and TIMM23B has identified putative binding sites for transcription factors GA-binding protein (GABP) and recombination signal binding protein for immunoglobulin kappa J (RBPJ) .

  Experimental approaches for studying transcriptional regulation:

  • Luciferase reporter assays with TIMM23B promoter constructs

  • Electrophoretic mobility shift assays (EMSAs) to detect protein-DNA interactions

  • Chromatin immunoprecipitation (ChIP) to identify in vivo binding of transcription factors

  • Silencing of transcription factors (e.g., GABPA) followed by assessment of TIMM23B expression

  Studies have shown that silencing GABPA (the gene encoding the DNA-binding subunit of the GABP transcription factor) reduces expression of both TIMM23 and TIMM23B, indicating an essential role of GABP in activating their expression .

• What is the role of TIMM23B in cancer biology and how can it be targeted therapeutically?

  Based on research with TIMM23, TIMM23B may play a significant role in cancer biology. TIMM23 overexpression has been linked to adverse clinical outcomes in non-small cell lung cancer (NSCLC) patients, with elevated expression within cancer cells of NSCLC tumors .

  Experimental evidence shows that silencing or ablation of TIMM23 impairs mitochondrial function in cancer cells, leading to:

  • Reduced complex I activity and ATP depletion

  • Mitochondrial membrane potential dissipation

  • Increased oxidative stress and lipid peroxidation

  • Attenuated cell viability, proliferation, and migration

  • Induction of apoptosis

  Therapeutic targeting strategies and research methods:

  • Development of specific inhibitors targeting TIMM23B channel function

  • RNA interference approaches (shRNA, siRNA) for selective knockdown

  • Viral vector delivery systems (e.g., AAV) for in vivo targeting

  • Assessment of combinatorial approaches with conventional chemotherapeutics

  • Screening for synthetic lethal interactions in cancer contexts

  In vivo studies have shown that intratumoral delivery of TIMM23 shRNA-expressing adeno-associated virus significantly suppresses the growth of subcutaneous NSCLC xenografts in nude mice, suggesting similar approaches might be effective for TIMM23B .

• How can post-translational modifications of TIMM23B be identified and what functional impacts might they have?

  Post-translational modifications (PTMs) likely regulate TIMM23B function, stability, and interactions, though specific modifications of TIMM23B have not been extensively characterized in the literature.

  Methodological approaches to study PTMs:

  PTM Type	Detection Method	Potential Functional Impact	Research Approach
  Phosphorylation	Mass spectrometry, phospho-specific antibodies	Regulation of channel activity or protein interactions	Site-directed mutagenesis of potential phosphorylation sites
  Ubiquitination	Ubiquitin pull-down, mass spectrometry	Protein stability and turnover	Proteasome inhibition studies, ubiquitin chain-specific antibodies
  Oxidation	Redox proteomics	Response to oxidative stress	Oxidation-resistant mutants, effects of antioxidants
  Disulfide bonds	Non-reducing SDS-PAGE	Structural integrity of the complex	Mutation of cysteine residues, effects of reducing agents

  Research in yeast Tim17 has shown that intramolecular disulfide bonds are crucial for TIM23 complex function, with their absence significantly impairing import ability . Similar disulfide bonds may exist in TIMM23B and could be essential for its function.

• What are the optimal methods for producing and purifying recombinant TIMM23B for biochemical studies?

  Producing functional recombinant TIMM23B presents challenges due to its transmembrane nature, but several approaches can be employed:

  Expression and purification strategies:

  1. Bacterial expression systems:

     • Use of specialized E. coli strains (e.g., C41/C43) designed for membrane protein expression

     • Fusion with solubility tags (MBP, GST, SUMO)

     • Cell-free expression systems

  2. Eukaryotic expression systems:

     • Insect cell (Sf9, High Five) expression using baculovirus

     • Mammalian cell expression in HEK293 or CHO cells

     • Yeast expression systems (P. pastoris)

  3. Purification approaches:

     • Detergent solubilization optimization (DDM, LMNG, GDN)

     • Nanodisc or amphipol reconstitution for stability

     • Affinity chromatography with polyhistidine or other tags

     • Size exclusion chromatography for final polishing

  4. Functional validation:

     • Liposome reconstitution assays

     • Channel activity measurements

     • Substrate protein binding assays

     • Structural studies (cryo-EM, X-ray crystallography)

  For biochemical studies requiring large amounts of protein, the baculovirus-insect cell system often provides the best balance of yield and proper folding for mitochondrial membrane proteins.